Navigation Links
Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
Date:11/3/2009

n 18-month period, sell up to $60 million newly issued registered common stock to Azimuth Opportunity Ltd. at a pre-negotiated discount to market price. The Company will determine, at its sole discretion, the timing and amount of any sales of its common stock, subject to certain conditions. The Company is not obligated to utilize any of the $60 million facility and remains free to enter into other financing transactions.

Third Quarter 2009 Unaudited Financial Results

The Company reported a net loss of $9.9 million ($0.29 diluted loss per share on a loss applicable to common shares of $10.0 million) for the quarter ended September 30, 2009, compared with a net loss of $12.2 million ($0.36 diluted loss per share on a loss applicable to common shares of $12.4 million) for the quarter ended September 30, 2008. The Company reported a net loss of $32.5 million ($0.95 diluted loss per share on a loss applicable to common shares of $32.9 million) for the nine months ended September 30, 2009, compared with a net loss of $34.6 million ($1.01 diluted loss per share on a loss applicable to common shares of $35.0 million) for the same period in 2008.

Total operating expenses for the quarter ended September 30, 2009, were $9.2 million compared with $12.4 million for the quarter ended September 30, 2008, and were $30.5 million for the nine months ended September 30, 2009, compared with $35.8 million for the same period in 2008. Total operating expenses for the nine months ended September 30, 2009, include a charge of $1.1 million for the restructuring and related asset impairment resulting from the Company's implementation of a strategic restructuring plan to discontinue its in-house preclinical research operations and reduce its workforce by approximately 12 percent effective March 31, 2009.

Research and development expenses were $5.4 million for the quarter ended September 30, 2009, compared with $9.0 million for
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Poniard Pharmaceuticals to Present at the 2009 UBS Global Life Sciences Conference
2. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
3. Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September
4. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
5. Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
6. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
7. Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
8. Poniard Pharmaceuticals Files Shelf Registration
9. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
10. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
11. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... DIEGO , May 5, 2015  Orexigen Therapeutics, ... for the first quarter 2015 on Friday, May 8 ... by a live webcast and conference call at 8:30 ... The live call may be accessed by phone by ... code 39586962. The webcast can be accessed live on ...
(Date:5/5/2015)... Station, TX (PRWEB) May 05, 2015 ... were announced last week as recipients of the ... Innovation in recognition of their Portable, Continuous, Miniature ... that integrates a small footprint, continuous processing equipment, ... modules) to process API powders and inactive ingredients ...
(Date:5/5/2015)... MA (PRWEB) May 05, 2015 The ... ), a Massachusetts-based non-profit operating in the public interest, ... affiliate of the Hearst Communications Company, have formed a ... for public outreach and education across the healthcare and ... for the voice of patients and the public to ...
(Date:5/4/2015)... JSS Medical Research Inc., a Montreal based ... of Max Neeman International (MNI), with head office in ... Ahmedabad, Bangalore , Chennai ... regional office is located North Carolina, USA . ... equity investment transaction into JSS with Capital Croissance PME (CCPME), a ...
Breaking Biology Technology:GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3ACRES and San Antonio Express-News Launch Blog on Accountability in Clinical Research 2ACRES and San Antonio Express-News Launch Blog on Accountability in Clinical Research 3ACRES and San Antonio Express-News Launch Blog on Accountability in Clinical Research 4JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4
... , ... unemployment rate remained unchanged, health care added another 20,000 jobs. Layoffs were also ... , ... the United States unemployment rate remained unchanged in February, health care continued to add jobs, ...
... which current flows without resistance, have tantalizing applications. But ... effect kicks in, so researchers want to know when ... it into existence at room temperature. Now a ... areas of weak superconductivity hold up at higher temperatures ...
... PLYMOUTH MEETING, Pa. , March 15 ... the "Company") today,announced financial results for the fourth quarter and fiscal year ... 2009 Financial Highlights:, -- Revenue increased to $41.5 million, ... quarter of 2008;, -- Gross profit increased 21% to ...
Cached Biology Technology:The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again 2The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again 3The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again 4Superconductors on the nanoscale 2BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 2BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 3BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 4BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 5BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 6BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 7BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 8BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 9BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 10BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 11BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 12BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 13BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 14BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 15BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 16
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... BOSTON, Mass , March 23, 2015 SoundView ... shipment of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView ... world user feedback on their experience with the Wocket in ... experience at CVS, Whole Foods and other retailers, making both ... Kris Tuttle also says, "If the company meets ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... Department of Materials Science and Engineering at the University ... Materials Science and Technology Division at the Oak Ridge ... of Engineering. He becomes the fifth NAE member in ... the NAE is among the highest professional distinctions accorded ...
... from the University of California, San Diego School of ... broadly regulates how genetic information transcribed from DNA to ... the myriad of proteins necessary for life. The ... , help explain how a relatively limited number of ...
... biomarkers of cardiovascular disease: implications for heart-healthy diets," published ... examined 26 clinical studies and two meta-analyses to assess ... Of the probiotics examined, L. reuteri NCIMB 30242 (Cardioviva) ... dietary requirements by: , Significantly reducing ...
Cached Biology News:University of Tennessee professor named to National Academy of Engineering 2Global regulator of mRNA editing found 2Heart health through gut health 2
HistoScan AP Universal Goat Kit...
Anti-rat Ig HRP detection kit...
4',6-Diamidino-2-phenylindole dihydrochloride...
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
Biology Products: